CMS Ends Federal Medicaid, CHIP Funding For Gender-Transition Procedures For Minors

MT Newswires Live08-12

The Centers for Medicare & Medicaid Services said Tuesday it finalized a rule ending federal Medicaid and CHIP funding for puberty blockers, cross-sex hormones and surgical procedures for children and youth.

The rule provides a tapering-off period of up to six months after its Oct. 13 effective date for children currently receiving hormone therapy, CMS said. It does not affect coverage of mental health services.

CMS said the decision follows an HHS review that identified evidence gaps and safety concerns surrounding the procedures. HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz said the policy is intended to protect children and safeguard federal healthcare funds.

The rule applies only to federal Medicaid and CHIP funding, CMS said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment